Correlation Between Syndax Pharmaceuticals and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Pharvaris BV, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Pharvaris.
Diversification Opportunities for Syndax Pharmaceuticals and Pharvaris
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Syndax and Pharvaris is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Pharvaris go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Pharvaris
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.25 times more return on investment than Pharvaris. However, Syndax Pharmaceuticals is 1.25 times more volatile than Pharvaris BV. It trades about 0.18 of its potential returns per unit of risk. Pharvaris BV is currently generating about 0.1 per unit of risk. If you would invest 999.00 in Syndax Pharmaceuticals on July 24, 2025 and sell it today you would earn a total of 521.00 from holding Syndax Pharmaceuticals or generate 52.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Pharvaris BV
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Pharvaris BV |
Syndax Pharmaceuticals and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Pharvaris
The main advantage of trading using opposite Syndax Pharmaceuticals and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Syndax Pharmaceuticals vs. Immunome | Syndax Pharmaceuticals vs. Amylyx Pharmaceuticals | Syndax Pharmaceuticals vs. Oric Pharmaceuticals | Syndax Pharmaceuticals vs. Sana Biotechnology |
| Pharvaris vs. Syndax Pharmaceuticals | Pharvaris vs. Oric Pharmaceuticals | Pharvaris vs. Zymeworks Common Stock | Pharvaris vs. Amylyx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |